Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Mohit Neema, M.D.

TitleInstructor in Neurology
InstitutionBrigham and Women's Hospital
DepartmentNeurology
AddressBrigham and Women's Hospital
Suite 602
One Brookline Pl
Brookline MA 02445
Phone617/732-6888

 Biography 
 awards and honors
2009 - William H. Oldendorf Award
2009 - 2010Nominee, Excellence in Mentoring Award
2010 - John and Sophie Prockop Memorial Lectureship
2010 - Young Investigator Travel Award
2010 - Best Poster Award - finalist
2010 - 2011Partners In Excellence Award

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ceccarelli A, Bakshi R, Neema M. MRI in multiple sclerosis: a review of the current literature. Curr Opin Neurol. 2012 Aug; 25(4):402-9.
    View in: PubMed
  2. Neema M, Ceccarelli A, Jackson JS, Bakshi R. Multiple Sclerosis: Diagnosis and Therapy (eds Weiner and Stankiewicz). Magnetic Resonance Imaging in Multiple Sclerosis. 2012.
  3. Ceccarelli A, Jackson JS, Tauhid S, Arora A, Gorky J, Dell'Oglio E, Bakshi A, Chitnis T, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R, Neema M. The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis. AJNR Am J Neuroradiol. 2012 Sep; 33(8):1579-85.
    View in: PubMed
  4. Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han XM, Venkataraman A, Chitnis T, Khoury SJ, Guttmann CR, Weiner HL, Neema M, Bakshi R. Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study. J Neurol Sci. 2012 Apr 15; 315(1-2):49-54.
    View in: PubMed
  5. Healy BC, Arora A, Hayden DL, Ceccarelli A, Tauhid SS, Neema M, Bakshi R. Approaches to normalization of spinal cord volume: application to multiple sclerosis. J Neuroimaging. 2012 Jul; 22(3):e12-9.
    View in: PubMed
  6. Klein JP, Arora A, Neema M, Healy BC, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Stankiewicz JM, Cohen AB, Buckle GJ, Houtchens MK, Ceccarelli A, Dell'Oglio E, Guttmann CR, Alsop DC, Hackney DB, Bakshi R. A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol. 2011 Jun-Jul; 32(6):1138-42.
    View in: PubMed
  7. Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RH, Guss ZD, Tauhid S, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R. Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimaging. 2011 Apr; 21(2):e50-6.
    View in: PubMed
  8. Cohen AB, Neema M, Arora A, Dell'oglio E, Benedict RH, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Ceccarelli A, Klein JP, Stankiewicz JM, Houtchens MK, Buckle GJ, Alsop DC, Guttmann CR, Bakshi R. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging. 2012 Apr; 22(2):122-8.
    View in: PubMed
  9. Neema M, Bakshi R. Update in neuroimaging. Neurotherapeutics. 2011 Jan; 8(1):2.
    View in: PubMed
  10. Horsfield MA, Sala S, Neema M, Absinta M, Bakshi A, Sormani MP, Rocca MA, Bakshi R, Filippi M. Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage. 2010 Apr 1; 50(2):446-55.
    View in: PubMed
  11. Ceccarelli A, Rocca MA, Neema M, Martinelli V, Arora A, Tauhid S, Ghezzi A, Comi G, Bakshi R, Filippi M. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult Scler. 2010 Jan; 16(1):39-44.
    View in: PubMed
  12. Ceccarelli A, Filippi M, Neema M, Arora A, Valsasina P, Rocca MA, Healy BC, Bakshi R. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler. 2009 Jun; 15(6):678-86.
    View in: PubMed
  13. Gauthier SA, Glanz BI, Mandel M, Tsagkaropoulos A, Neema M, Stankiewicz J, Arora A, Duan Y, Liptak Z, Egorova S, Buckle GJ, Bakshi R, Guttmann CR, Khoury SJ, Weiner HL. Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study. J Neurol Sci. 2009 Sep 15; 284(1-2):116-9.
    View in: PubMed
  14. Stankiewicz JM, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CR, Hackney D, Bakshi R. Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study. J Neurol Sci. 2009 Apr 15; 279(1-2):99-105.
    View in: PubMed
  15. Neema M, Guss ZD, Stankiewicz JM, Arora A, Healy BC, Bakshi R. Normal findings on brain fluid-attenuated inversion recovery MR images at 3T. AJNR Am J Neuroradiol. 2009 May; 30(5):911-6.
    View in: PubMed
  16. Neema M, Goldberg-Zimring D, Guss ZD, Healy BC, Guttmann CR, Houtchens MK, Weiner HL, Horsfield MA, Hackney DB, Alsop DC, Bakshi R. 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage. 2009 Jul 1; 46(3):633-41.
    View in: PubMed
  17. Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y, Buckle GJ, Glanz BI, Stazzone L, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging. 2009 Jan; 19(1):3-8.
    View in: PubMed
  18. Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, Weiner HL. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol. 2008 Nov; 65(11):1449-53.
    View in: PubMed
  19. Arora A, Neema M, Stankiewicz J, Guss ZD, Guss JG, Prockop L, Bakshi R. Neuroimaging of toxic and metabolic disorders. Semin Neurol. 2008 Sep; 28(4):495-510.
    View in: PubMed
  20. Stankiewicz J, Glanz B, Healy BC, Benedict RHB, Arora A, Neema M, Guss ZD, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CRG, Bakshi R. Brain MRI lesion volume correlates with physical disability and cognitive impairment in patients with multiple sclerosis: a comparison of 1.5T and 3T. 2008 Annual Meeting of the American Academy of Neurology, Chicago, IL. 2008.
  21. Guss ZD, Stankiewicz J, Neema M, Arora A, Bakshi R. . To describe brain hyperintensities detected in normal volunteers on FLAIR MRI using both 1.5T and 3T. 2008 Annual Meeting of the American Academy of Neurology, Chicago, IL. 2008.
  22. Arora A, Neema M, Stankiewicz J, Guss JG, Bakshi R. . Regional and whole spinal cord atrophy in multiple sclerosis. 2008 Annual Meeting of the American Academy of Neurology, Chicago, IL. 2008.
  23. Neema M, Alsop D, Guss ZD, Houtchens MK, Weiner HL, Bakshi R. . 3T MRI relaxometry detects T2 prolongation in normal-appearing white matter in multiple sclerosis. 2008 Annual Meeting of the American Academy of Neurology, Chicago, IL. 2008.
  24. Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y, Buckle GJ, Glanz B, Stazzone L, Khoury SJ, Weiner HL, Guttmann CRG, Bakshi R. . Gray matter damage on brain MRI scans is associated with clinical progression in multiple sclerosis. 2008 Annual Meeting of the American Academy of Neurology, Chicago, IL. 2008.
  25. Stankiewicz J, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CRG, Hackney DB, Bakshi R. . Whole spinal cord lesion detection with 1.5T and 3T MRI and clinical correlation in multiple sclerosis. 2008 Annual Meeting of the American Academy of Neurology, Chicago, IL. 2008.
  26. Arora A, Neema M, Stankiewicz J, Guss JG, Bakshi R. MRI Measurement of Whole Spinal Cord Volume at 3T: Reproducibility and Relevance to Multiple Sclerosis. 10th Annual Meeting of the American Society for Experimental NeuroTherapeutics, Arlington, VA. 2008.
  27. Stankiewicz J, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CRG, Hackney DB, Bakshi R. . Whole spinal cord lesion detection with 1.5T and 3T MRI and clinical correlation in multiple sclerosis. First joint meeting of ACTRIMS, ECTRIMS and LACTRIMS. 2008.
  28. Glanz B, Stankiewicz J, Healy BC, Benedict RHB, Arora A, Neema M, Guss ZD, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CRG, Bakshi R. Brain MRI lesion volume correlates with physical disability and cognitive impairment in patients with multiple sclerosis: a comparison of 1.5T and 3T. First joint meeting of ACTRIMS, ECTRIMS and LACTRIMS. 2008.
  29. Neema M, Alsop D, Guss ZD, Houtchens MK, Weiner HL, Bakshi R. . 3T MRI relaxometry detects T2 prolongation in the global and regional brain normal-appearing white matter in multiple sclerosis. First joint meeting of ACTRIMS, ECTRIMS and LACTRIMS. 2008.
  30. Guss ZD, Stankiewicz J, Neema M, Arora A, Bakshi R. . To describe brain hyperintensities detected in normal volunteers on FLAIR MRI using both 1.5T and 3T. First joint meeting of ACTRIMS, ECTRIMS and LACTRIMS. 2008.
  31. Moodie J, Neema M, Healy BC, Buckle GJ, Gauthier SA, Glanz B, Khoury SJ, Guttmann CRG, Weiner H, Bakshi R. . Magnetic Resonance Disease Severity Scale (MRDSS) for patients with multiple sclerosis: a longitudinal study. First joint meeting of ACTRIMS, ECTRIMS and LACTRIMS. 2008.
  32. Bakshi R, Neema M, Healy B, Liptak Z, Betensky R, Buckle G, Gauthier S, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury S, Guttmann CRG, Weiner HL . Magnetic Resonance Disease Severity Scale (MRDSS) Predicts Clinical Progression in Multiple Sclerosis. 10th Annual Meeting of the American Society for Experimental NeuroTherapeutics, Arlington, VA. 2008.
  33. Goldberg-Zimring D, Neema M, Sharma J, Jaisani Z, Singh B, Bakshi R. Deep gray matter atrophy is associated with T2 hypointensity in secondary progressive multiple sclerosis. First joint meeting of ACTRIMS, ECTRIMS and LACTRIMS. 2008.
  34. Neema M, Stankiewicz J, Arora A, Guss ZD, Bakshi R. MRI in multiple sclerosis: what's inside the toolbox? Neurotherapeutics. 2007 Oct; 4(4):602-17.
    View in: PubMed
  35. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007 Jul; 4(3):371-86.
    View in: PubMed
  36. Neema M, Stankiewicz J, Arora A, Dandamudi VS, Batt CE, Guss ZD, Al-Sabbagh A, Bakshi R. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging. 2007 Apr; 17 Suppl 1:16S-21S.
    View in: PubMed
  37. Bakshi R, Neema M, Liptak Z, Betensky R, Buckle G, Gauthier S, Stankiewicz J, Meier D, Egorova S, Arora A, Dandamudi V, Batt CE, Guss ZD, Glanz B, Khoury S, Guttmann C, Weiner H . Magnetic resonance disease severity scale (MRDSS) predicts clinical progression in multiple sclerosis. 2007 Annual Meeting of the American Academy of Neurology, Boston, MA. Neurology. 2007; 68(Suppl 1):A53.
  38. Neema M, Dandamudi VSR, Arora A, Stankiewicz J, Bakshi R . T1 black holes and gray matter damage. Filippi M, Rovaris M, Comi G (eds) Neurodegeneration in Multiple Sclerosis. 2007; 37-45.
  39. Neema M. The Roles of DNA-PKcs in Adult Neuronal Survival and Hippocampal Neurogenesis after Kainate-Induced Seizures. 2006.
  40. Bakshi R, Neema M, Houtchens M, Napoli S, Dandamudi VSR, De C, Guttmann CRG . MRI Measurement of Whole Spinal Cord Volume at 3T: Reproducibility and Relevance to Multiple Sclerosis. 2006 Annual Meeting of the American Academy of Neurology, San Diego CA. Neurology. 2006; 68(Suppl 1):A54.
  41. Neema M, Navarro-Quiroga I, Chechlacz M, Gilliams-Francis K, Liu J, Lamonica K, Lin SL, Naegele JR. DNA damage and nonhomologous end joining in excitotoxicity: neuroprotective role of DNA-PKcs in kainic acid-induced seizures. Hippocampus. 2005; 15(8):1057-71.
    View in: PubMed
  42. Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging. 2005; 15(4 Suppl):30S-45S.
    View in: PubMed
  43. Neema M, Lamonica K, Quiroga IN, Naegele JR. Decreased survival of pyramidal neurons in the hippocampus of DNA repair deficient mice following kainic acid induced seizures. 34th Annual Meeting of the Society for Neuroscience, San Diego, CA. 2004.
  44. Liu J, Neema M, Lin SL, Naegele JR . Involvement of extracellular signal-regulated kinase and BAX in kainate-induced excitotoxic cell death. 34th Annual Meeting of the Society for Neuroscience, San Diego, CA. 2004.
  45. Narasimhaiah R, Quiroga IN, Lin SL, Neema M, Valdes MH, Naegele JR . Impaired neuronal survival in the rostral migratory stream of DNA break repair deficit mice. 34th Annual Meeting of the Society for Neuroscience, San Diego, CA. 2004.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Neema's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (99) concept(s)
_
Co-Authors
See all (22) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_